0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-17.54%
Cash & equivalents declining -17.54% while ECL.AX's grows 405.53%. Howard Marks would question why our liquidity is shrinking while competitor builds cash.
No Data
No Data available this quarter, please select a different quarter.
-17.54%
Below half of ECL.AX's 395.28%. Michael Burry might suspect a liquidity shortfall if there's no alternative capital plan.
13.98%
Receivables growth less than half of ECL.AX's -38.32%. David Dodd might see more conservative credit practices, provided revenue isn't suffering.
-34.54%
Inventory growth 50-75% of ECL.AX's -55.04%. Bruce Berkowitz sees relatively tighter stock. Confirm sales aren't sacrificed.
No Data
No Data available this quarter, please select a different quarter.
-8.25%
Below half of ECL.AX's 9.49%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
-13.53%
Below half ECL.AX's -88.71%. Michael Burry sees potential underinvestment risk unless there's a valid reason (asset-light model).
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.79%
Below half of ECL.AX's -38.88%. Michael Burry might suspect stagnation or lack of resources for expansions.
No Data
No Data available this quarter, please select a different quarter.
-8.29%
≥ 1.5x ECL.AX's -2.32%. David Dodd notes a larger balance sheet expansion. Confirm it's not overleveraged.
-69.57%
Similar yoy growth to ECL.AX's -67.60%. Walter Schloss sees parallel payables strategy. Check top-line correlation.
198.00%
Higher Short-Term Debt Growth compared to ECL.AX's zero value, indicating worse performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.49%
50-75% of ECL.AX's -37.18%. Bruce Berkowitz notes the firm keeps current liabilities growth relatively low.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Higher Other Liabilities Growth compared to ECL.AX's zero value, indicating worse performance.
-23.79%
50-75% of ECL.AX's -37.18%. Bruce Berkowitz notes a lower yoy liability increase.
No Data
No Data available this quarter, please select a different quarter.
1.38%
Below half ECL.AX's 20.78%. Michael Burry suspects major net losses or high dividends vs. competitor.
5067.34%
Less than half of ECL.AX's -2.82%. David Dodd sees fewer intangible or market-driven swings than competitor.
24143865444.22%
Less than half of ECL.AX's -5.01%. David Dodd notes simpler yoy equity changes vs. competitor.
297.66%
≥ 1.5x ECL.AX's 4.01%. David Dodd sees stronger capital base growth than competitor.
-8.29%
≥ 1.5x ECL.AX's -1.82%. David Dodd sees faster overall balance sheet growth than competitor.
No Data
No Data available this quarter, please select a different quarter.
208.14%
Higher Total Debt Growth compared to ECL.AX's zero value, indicating worse performance.
479.81%
Less than half of ECL.AX's -405.53%. David Dodd sees better deleveraging or stronger cash buildup than competitor.